参考文献/References:
[1] Estes C,Razavi H,Loomba R,et al.Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease[J]. Hepatology,2018,67(1):123-133.DOI:10.1002/hep.29466.
[2] Li Q,Dhyani M,Grajo JR,et al.Current status of imaging in nonalcoholic fatty liver disease[J].World J Hepatol,2018,10(8):530-542.DOI:10.4254/wjh.v10.i8.530.
[3] Loomba R,Seguritan V,Li W,et al.Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease[J].Cell Metab,2017,25(5):1054-1062.DOI:10.1016/j.cmet.2017.04.001.
[4] Aparna P,Muthathal S,Nongkynrih B,et al.Vitamin D deficiency in India[J].J Family Med Prim Care,2018,7(2):324-330.DOI:10.4103/jfmpc.jfmpc_78_18.
[5] Cho YH,Kim JW,Shim JO,et al.Association between vitamin D deficiency and suspected nonalcoholic fatty liver disease in an adolescent population[J].Pediatr Gastroenterol Hepatol Nutr,2019,22(3):233-241.DOI:10.5223/pghn.2019.22.3.233.
[6] Sakpal M,Satsangi S,Mehta M,et al.Vitamin D supplementation in patients with nonalcoholic fatty liver disease: a randomized controlled trial[J].JGH Open,2017,1(2):62-67.DOI:10.1002/jgh3.12010.
[7] Sender R,Fuchs S,Milo R.Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans[J].Cell,2016,164(3):337-340.DOI:10.1016/j.cell.2016.01.013.
[8] Tun HM,Bridgman SL,Chari R,et al.Roles of birth mode and infant gut microbiota in intergenerational transmission of overweight and obesity from mother to offspring[J].JAMA Pediatr,2018,172(4):368-377.DOI:10.1001/jamapediatrics.2017.5535.
[9] Wang J,Thingholm LB,Skiecevicˇiené J,et al.Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota[J].Nat Genet,2016,48(11):1396-1406.DOI:10.1038/ng.3695.
[10] International journal of molecular science editorial office. International journal of molecular science 2017 best paper award[J].Int J Mol Sci,2017,18(11):pii:E2310.DOI:10.3390/ijms18112310.
[11] Nonn L,Peng L,Feldman D,et al.Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D[J].Cancer Res,2006,66(8):4516-4524.DOI:10.1158/0008-5472.CAN-05-3796.
[12] Chen J,Waddell A,Lin YD,et al.Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells[J].Mucosal Immunol,2015,8(3):618-626.DOI:10.1038/mi.2014.94.
[13] Zhu W,Yan J,Zhi C,et al.1,25(OH)2D3 deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model[J].Gut Pathog,2019,11:8.DOI:10.1186/s13099-019-0291-z.
[14] 王磊,焦先婷,魏真真,等.孕前和孕期维生素 D缺乏对子代大鼠肠道菌群及抗菌肽 cathelicidin的影响[J].上海交通大学学报(医学版),2018,38(8),875-880. DOI:10.3969/j.issn.1674-8115.2018.08.004.
[15] 昌雪莲,尚煜,刘雅静,等.母孕期和婴儿早期钙剂补充对婴儿BMI及肠道菌群的影响[J]. 中华预防医学杂志, 2018, 52(6):642-646. DOI:10.3760/cma.j.issn.0253-9624.2018.06.014.
[16] Tilg H,Moschen AR.Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis[J].Hepatology,2010, 52(5):1836-1846.DOI:10.1002/hep.24001.
[17] Acharya C,Bajaj JS.Gut microbiota and complications of liver disease[J].Gastroenterol Clin North Am,2017,46(1):155-169.DOI:10.1016/j.gtc.2016.09.013.
[18] Lim MY,You HJ,Yoon HS,et al.The effect of heritability and host genetics on the gut microbiota and metabolic syndrome[J].Gut,2017,66(6):1031-1038.DOI:10.1136/gutjnl-2015-311326.
[19] Yiu JH,Dorweiler B,Woo CW.Interaction between gut microbiota and toll-like receptor: from immunity to metabolism[J].J Mol Med(Berl),2017,95(1):13-20.DOI:10.1007/s00109-016-1474-4.
[20] Kanmani P,Kim H.Protective effects of lactic acid bacteria against TLR4 induced inflammatory response in hepatoma HepG2 cells through modulation of toll-like receptor negative regulators of mitogen-activated rrotein kinase and NF-κB signaling[J].Front Immunol,2018,9:1537. DOI:10.3389/fimmu.2018.01537.
[21] Liang Y,Lin C,Zhang Y,et al.Probiotic mixture of Lactobacillus and Bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate[J].Inflammopharmacology,2018,26(4):1051-1055.DOI:10.1007/s10787-018-0479-8.
[22] Yadav AK,Tyagi A,Kumar A,et al.Adhesion of Lactobacilli and their anti-infectivity potential[J].Crit Rev Food Sci Nutr,2017,57(10):2042-2056.DOI:10.1080/10408398.2014.918533.
[23] Woodhouse CA,Patel VC,Singanayagam A,et al.Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease[J].Aliment Pharmacol Ther,2018,47(2):192-202.DOI:10.1111/apt.14397.
[24] Takada I,Makishima M.Control of inflammatory bowel disease and colorectal cancer by synthetic vitamin D receptor ligands[J].Curr Med Chem,2017,24(9):868-875.DOI:10.2174/0929867323666161202145509.
[25] Jin D,Wu S,Zhang YG,et al.Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome[J].Clin Ther,2015,37(5):996-1009.e7.DOI:10.1016/j.clinthera.2015.04.004.
[26] Yang SQ,Lin HZ,Lane MD,et al.Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis[J].Proc Natl Acad Sci U S A,1997,94(6):2557-2562.DOI:10.1073/pnas.94.6.2557.
[27] Barbáchano A,Fernández-Barral A,Ferrer-Mayorga G,et al.The endocrine vitamin D system in the gut[J].Mol Cell Endocrinol,2017,453:79-87.DOI:10.1016/j.mce.2016.11.028.
[28] Stio M,Retico L,Annese V,et al.Vitamin D regulates the tight-junction protein expression in active ulcerative colitis[J].Scand J Gastroenterol,2016,51(10):1193-1199.DOI:10.1080/00365521.2016.1185463.
[29] Wang F,Johnson RL,DeSmet ML,et al.Vitamin D receptor-dependent signaling protects mice from dextran sulfate sodium-induced colitis[J].Endocrinology,2017,158(6):1951-1963.DOI:10.1210/en.2016-1913.
[30] Su D,Nie Y,Zhu A,et al.Vitamin D signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models[J].Front Physiol,2016,7:498.
[31] Yu S,Bruce D,Froicu M,et al.Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice[J].Proc Natl Acad Sci U S A,2008,105(52):20834-20839. DOI:10.1073/pnas.0808700106.
相似文献/References:
[1]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[2]冯娟,夏维波.维生素D结合蛋白研究进展[J].国际内分泌代谢杂志,2016,36(03):209.[doi:10.3760/cma.j.issn.1673-4157.2016.03.17]
Feng Juan,Xia Weibo.Research progress of vitamin D binding protein[J].International Journal of Endocrinology and Metabolism,2016,36(05):209.[doi:10.3760/cma.j.issn.1673-4157.2016.03.17]
[3]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(05):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[4]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(05):270.
[5]顾子良 王洪东 朱大龙 毕艳.2型糖尿病治疗方法对肠道菌群的影响[J].国际内分泌代谢杂志,2018,38(04):254.[doi:10.3760/cma.j.issn.1673-4157.2018.04.009]
Gu Ziliang,Wang Hongdong,Zhu Dalong,et al.Effects of treatment of type 2 diabetes on gut microbiota[J].International Journal of Endocrinology and Metabolism,2018,38(05):254.[doi:10.3760/cma.j.issn.1673-4157.2018.04.009]
[6]陈俊秀 杜宏.肠道菌群与口服降糖药物[J].国际内分泌代谢杂志,2018,38(05):305.[doi:10.3760/cma.j.issn.1673-4157.2018.05.005]
Chen Junxiu*,Du Hong.Intestinal microbiota and oral hypoglycemic agents[J].International Journal of Endocrinology and Metabolism,2018,38(05):305.[doi:10.3760/cma.j.issn.1673-4157.2018.05.005]
[7]夏心怡 张洪梅.肠道菌群及其代谢产物调节糖脂代谢的机制[J].国际内分泌代谢杂志,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
Xia Xinyi,Zhang Hongmei.Regulating mechanism of glycolipid metabolism by intestinal microbiota and its metabolites[J].International Journal of Endocrinology and Metabolism,2018,38(05):309.[doi:10.3760/cma.j.issn.1673-4157.2018.05.006]
[8]周晓聪 张晓黎.益生菌与妊娠糖尿病的相关性[J].国际内分泌代谢杂志,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
Zhou Xiaocong,Zhang Xiaoli.Relationship between probiotics and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(05):313.[doi:10.3760/cma.j.issn.1673-4157.2018.05.007]
[9]万仕炜 郁梅 方彭华 张真稳.小檗碱改善胰岛素抵抗的相关机制[J].国际内分泌代谢杂志,2018,38(05):333.[doi:10.3760/cma.j.issn.1673-4157.2018.05.012]
Wan Shiwei*,Yu Mei,Fang Penghua,et al.Related mechanism of berberine in improving insulin resistance[J].International Journal of Endocrinology and Metabolism,2018,38(05):333.[doi:10.3760/cma.j.issn.1673-4157.2018.05.012]
[10]袁昕 高四书 罗凯明 项守奎 华飞.维生素D缺乏对雌性大鼠糖脂代谢及卵巢
形态功能的影响[J].国际内分泌代谢杂志,2019,39(01):7.[doi:10.3760/cma.j.issn.1673-4157.2019.01.002]
Yuan Xin,Gao Sishu,Luo Kaiming,et al.Effects of vitamin D deficiency on glucolipid metabolism, morphology and function of ovary in female rats[J].International Journal of Endocrinology and Metabolism,2019,39(05):7.[doi:10.3760/cma.j.issn.1673-4157.2019.01.002]